Beryllium Lymphocyte Proliferation Test (BeLPT) for Naval Health Clinic Hawaii

The Defense Health Agency, on behalf of the Naval Health Clinic Hawaii, has awarded a sole-source firm fixed price contract (HT941026N0006) to National Jewish Health for Beryllium Lymphocyte Proliferation Test (BeLPT) services. This contract ensures compliance with OSHA medical surveillance mandates by providing sample processing, testing, interpretation, and reporting for an estimated 250 samples annually. The period of performance begins February 1, 2026, and runs through January 31, 2027, with four optional one-year extensions extending the potential term to January 31, 2031. The award was justified under FAR 13.501(a) because National Jewish Health is the only provider capable of meeting the critical 24 to 48 hour sample viability window required for specimens shipped from Hawaii to the contractor's CLIA-certified laboratory in Denver, Colorado. The contractor is responsible for providing all personnel, equipment, and supplies necessary to perform the tests, with results delivered via fax within 14 calendar days of sample receipt. Strict adherence to IATA shipping regulations, HIPAA privacy standards, and DHA security policies is required for the handling of protected health information and biological specimens. Key deliverables include a written Quality Control Plan submitted within 30 days of award and the maintenance of a designated Contract Manager. Performance is monitored through a Quality Assurance Surveillance Plan, and specimens may be rejected for leakage, improper labeling, or failure to arrive within the mandatory viability window.